Incyte to Present at Upcoming Investor Conferences
WILMINGTON, Del.–(BUSINESS WIRE)–
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June:
- William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023 at 11:20 a.m. (CDT)
- Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023 at 8:40 a.m. (PDT)
The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230518005001/en/
Incyte
Media
Catalina Loveman
+1 302 498 6171
[email protected]
Investors
Gregory Shertzer
+1 302 274 4779
[email protected]
KEYWORDS: Delaware United States North America
INDUSTRY KEYWORDS: Biotechnology General Health Pharmaceutical Health
MEDIA:
| Logo |
 |